Picture of Star Combo Pharma logo

S66 — Star Combo Pharma Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Annual cashflow statement for Star Combo Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSInterim ReportARS
Standards:
AAS
AAS
AAS
AAS
AAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.5410.1280.2610.4290.655
Other Operating Cash Flow
Cash from Operating Activities0.5341.88-0.31611.93.28
Capital Expenditures-7.29-2.73-1.44-0.394-2.45
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.05-0.51.3-9.330.433
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-3.24-3.23-0.137-9.72-2.02
Financing Cash Flow Items—-0.201-0.207-0.202-0.21
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.169-0.053-0.371-0.795-0.941
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.88-1.41-0.8241.430.315